Navigation Links
Anesthetix Launches OPTIMETRIX(TM) Perioperative Quality Management Tool
Date:8/27/2009

Anesthetix Management, LLC announces the rollout of its state-of-the-art computerized quality and service management tool, OPTIMETRIX(TM), reporting on over 80 data points, including Joint Commission Indicators, SCIP Indicators, PQRI, and HCAHPS measures. With OPTIMETRIX(TM) in place, a hospital's anesthesia and surgery department can work together on a real-time basis to measure and improve both the quality of care and the service they provide to their customers, helping establish themselves as the facility of choice to patients, surgeons, and payors.

Palm Beach Gardens, FL (PRWEB) August 27, 2009 -- Anesthetix Management, LLC (Anesthetix) announces the rollout of its state-of-the-art computerized quality and service management tool, OPTIMETRIX(TM).

OPTIMETRIX(TM) is the result of years of Anesthetix' well-honed clinical and business best practices in anesthesiology services and perioperative processes, and stems from Anesthetix' desire to prove its success and value in achieving the highest benchmark standards. It is a computerized, metrics-driven platform which allows Anesthetix' groups and hospital customers to continuously measure and improve clinical outcomes and operational processes. Notably, OPTIMETRIX(TM) incorporates an electronic data collections system to allow for comprehensive data collection, analysis and reporting, of over 80 data points, including Joint Commission Indicators, SCIP Indicators, PQRI, HCAHPS measures, timely OR case starts, improved surgeon and patient satisfaction, and productivity benchmarking metrics. With OPTIMETRIX(TM) in place, a hospital's anesthesia and surgery department can work together on a real-time basis to measure and improve both the quality of care and the service they provide to their customers, helping establish themselves as the facility of choice to patients, surgeons, and payors.

Under the direction of its Chief Medical Officer, Dr. Sonya Pease, Anesthetix is now offering OPTIMETRIX(TM) to hospitals and ASC's in addition to its turn-key anesthesia practice development and management service, providing valuable feedback to its facility and clinician partners on a regular basis and further enhancing the overall value proposition of Anesthetix to its hospitals, surgeons, anesthesiologists, patients, and insurers throughout the United States.

"At Anesthetix, we have always worked hard to 'set the standard' by developing, achieving and maintaining system-wide clinical and business 'best practices', and now with OPTIMETRIX(TM) we can concretely prove our success," said Steven M. Gottlieb, MD, President and CEO of Anesthetix. "Our goal is to constantly improve and evidence the superior care and service we provide at Anesthetix (e.g., low complication rates, minimized case delays and cancellations, faster case turnover times, improved operating room throughput, improved surgeon and patient satisfaction, etc.) and how this benefits our customers--hospitals, surgeons, patients, insurers. OPTIMETRIX(TM) allows us to go one step further and demonstrate our performance in a factual, data-driven manner, as opposed to just 'feeling like we're doing a good job'. It provides our facility and surgeon customers with added confidence in Anesthetix as their anesthesia partner."

Tushar Ramani, MD, Chief Operating Officer, added, "Hospitals today are investing more and more resources into protecting and growing their surgical service revenues, and in this environment, we understand that it is more important than ever for hospitals to hold their anesthesia service groups accountable for superior performance. OPTIMETRIX(TM) puts Anesthetix and our partners ahead of the curve by allowing us to proactively measure our success at delivering on our promise of top-notch, industry-leading medical care, and then go a step further by working to optimize our results."

About Anesthetix
Founded in 2000, Anesthetix Anesthetix Website is at the forefront of reinventing the delivery and management of anesthesia services. Working with nearly 200 anesthesiologists and CRNA's in 10 states, Anesthetix is developing a growing presence among healthcare providers and facilities. As a nationally recognized provider of comprehensive anesthesiology and pain management services for hospitals and surgery centers throughout the United States, Anesthetix is delivering unsurpassed quality and efficiency standards through its local, community-based physician groups.

About OPTIMETRIX(TM)
OPTIMETRIX(TM) is a state-of-the-art, proprietary tool, developed and owned by Anesthetix. It is an evidence-based, metrics-driven, platform utilized by Anesthetix to benchmark and optimize all aspects of perioperative patient care and processes. OPTIMETRIX(TM) provides our hospital and physician customers with continual reporting and benchmarking, as well as improvement plans, on over 80 quality and service indicators (e.g., Joint Commission Indicators, SCIP Indicators, PQRI/P4P, HCAHPS measures, Productivity Indicators, practitioner performance, surgeon satisfaction, patient satisfaction, etc) to continuously prove and improve clinical quality, OR efficiency, and service. To learn more about OPTIMETRIX(TM), please contact Dr. Steven Gottlieb, CEO, at 561.799.3552

CONTACT
Steven Gottlieb, MD
President and CEO
Telephone: 561.799.3552

###

Read the full story at http://www.prweb.com/releases/2009/08/prweb2792664.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Anesthetix Grows Practice Operations to 10 States
2. Home Delivery Medical Launches New Division For Sleep Centers
3. Solta Medical Launches New Fraxel re:store(R) Dual Laser System
4. Nuvilex Launches Last Shot Hangover Remedy(TM) Web Site
5. DATATRAK Launches New Web Site
6. Bariatric Advantage Launches Highly Anticipated RECOVER Program Through Obesity Action Coalition
7. American Medical Association Launches e-Book Strategy with iPublishCentral from Impelsys
8. Garden of Life Launches Lovely Legs(TM) to Reduce Visible Signs of Varicose and Spider Veins
9. Diplomat Specialty Pharmacy Partners With CareSource -- Launches Chronic Kidney Disease Management Program with Ohio Plan
10. Aflac Launches Soccer - Its Eighth New Television Ad for 2009
11. Oregon Company Launches National Campaign to Help Protect People with Intellectual Disabilities from the Swine Flu
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... (MRE), is pleased to be invited to the Siemens Healthineers annual customer education ... The event will take place from March 27 - 31, 2017 at ...
(Date:3/28/2017)... ... 2017 , ... The Thyroid Secret is a specialized 9-part ... program was recently launched on March 1, and Dr. Wentz discussed varied benefits ... Dr. Izabella Wentz is a licensed pharmacist and a foremost thyroid specialist. After ...
(Date:3/28/2017)... ... March 28, 2017 , ... City trips have ... World Travel Trends Report). As travelers visit both urban destinations, they are faced ... prolonged sun exposure. In response, the outdoor industry has blurred the lines between ...
(Date:3/28/2017)... , ... March 28, 2017 ... ... non-profit medical society dedicated to advancing the science and clinical practice of ... its RSSearch Patient Registry, a multi-institutional, observational registry established to standardize data ...
(Date:3/28/2017)... ... March 28, 2017 , ... Alert Sentry Group LLC., a leader in ... Response Systems), the iSAFE and the iSAFE Plus. These iSAFE products are the most ... kind, the iSAFE and iSAFE Plus offer direct GPS Location and two-way calling with ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... TAIPEI, Taiwan , March 28, 2017 /PRNewswire/ ... medical device company, is pleased to announce ... Series A investment of Panther Orthopedics, Inc., a ... pioneering innovative dynamic fixation solutions for orthopedic extremity ... market continues to expand rapidly, primarily due to ...
(Date:3/28/2017)... 28, 2017  "US Cancer Generics Market Outlook ... indicators and trend analysis related to the emergence ... pharmaceutical market in US. The report analyzes various ... on cancer generics drugs in recent years. The ... billions of dollars for various stake holders involved ...
(Date:3/28/2017)... Therapeutics, Inc. (Nasdaq: OREX ) today announced ... year ended December 31, 2016. "Last ... beginning with the re-acquisition of the rights to Contrave® ... at Orexigen demonstrated remarkable focus, executing on a myriad ... Company while rewarding us full control of our FDA ...
Breaking Medicine Technology: